AP
Asit Parikh

Asit Parikh insider trades: Phathom Pharmaceuticals (PHAT) stock purchases

Phathom Pharmaceuticals Last trade May 7, 2025 22 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
8
Open-market trades
since 2022
1
Company
last trade 2025

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Asit reports to the SEC

Open-market buys and sales

8 trades reported on SEC Form 4, newest first

DateStockTypeValue
May 7, 2025PHAT↑ Buy$25K
Mar 13, 2025PHAT↑ Buy$44K
Dec 13, 2024PHAT↑ Buy$81K
Nov 8, 2023PHAT↑ Buy$59K
Apr 10, 2023PHAT↑ Buy$8K
Feb 13, 2023PHAT↑ Buy$39K
Jan 12, 2023PHAT↑ Buy$35K
May 12, 2022PHAT↑ Buy$100K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About Asit Parikh's insider trades

Asit Parikh is an insider at Phathom Pharmaceuticals (PHAT). Since May 12, 2022, Asit has reported 8 open-market purchases worth $390K and no sales on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include grants and awards (8 filings), option exercises (4 filings), gifts (3 filings), shares returned to the company (2 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every PHAT insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.